Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat

Journal of Psychiatric Research

Volumn 82, Issue , 2016, Pages 109-118

  Kelly, John R ^a,b   Borre, Yuliya ^a   O’ Brien, Ciaran ^a,c   Patterson, Elaine ^a,c   El Aidy, Sahar ^a,d   Deane, Jennifer ^c   Kennedy, Paul J ^a   Beers, Sasja ^a   Scott, Karen ^a   Moloney, Gerard ^a   Hoban, Alan E ^a   Scott, Lucinda ^b   Fitzgerald, Patrick ^a   Ross, Paul ^c   Stanton, Catherine ^c   Clarke, Gerard ^a,b   Cryan, John F ^a,b   Dinan, Timothy G ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Brain gut axis; Depression; Gut microbiota; Inflammation; Intestinal barrier; Tryptophan

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; HYDROCORTISONE; KYNURENINE; LIPOPOLYSACCHARIDE BINDING PROTEIN; RNA 16S; TRYPTOPHAN; CORTICOSTERONE; LIPOPOLYSACCHARIDE;

ADOPTIVE TRANSFER; ADULT; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE FLORA; MAJOR DEPRESSION; MALE; MICROBIAL DIVERSITY; NEUROBIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RAT; RNA SEQUENCE; TRYPTOPHAN METABOLISM; AGED; ANIMAL; BLOOD; CASE CONTROL STUDY; DEPRESSION; DISEASE MODEL; FECES; FOOD PREFERENCE; GASTROINTESTINAL TRACT; MAZE TEST; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADULT; AGED; ANIMALS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORTICOSTERONE; CYTOKINES; DEPRESSION; DISEASE MODELS, ANIMAL; FECES; FEMALE; FOOD PREFERENCES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; HYDROCORTISONE; KYNURENINE; LIPOPOLYSACCHARIDES; MALE; MAZE LEARNING; MIDDLE AGED; RATS; RATS, SPRAGUE-DAWLEY; RNA, RIBOSOMAL, 16S;

EID: 84979955472     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2016.07.019     Document Type: Article

References (66)

1. Allen, A.P., Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Biological and psychological markers of stress in humans: focus on the trier social stress test. Neurosci. Biobehav. Rev. 38 (2014), 94–124.
2. Arrieta, M.C., Walter, J., Finlay, B.B., Human microbiota-associated mice: a model with challenges. Cell Host Microbe 19:5 (2016), 575–578.
3. Badawy, A.A., Morgan, C.J., Effects of acute paroxetine administration on tryptophan metabolism and disposition in the rat. Br. J. Pharmacol. 102:2 (1991), 429–433.
4. Badawy, A.A., Morgan, C.J., Dacey, A., Stoppard, T., The effects of lofepramine and desmethylimipramine on tryptophan metabolism and disposition in the rat. Biochem. Pharmacol. 42:4 (1991), 921–929.
5. Bailey, M.T., Dowd, S.E., Galley, J.D., Hufnagle, A.R., Allen, R.G., Lyte, M., Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain, Behav. Immun. 25:3 (2011), 397–407.
6. Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K.D., Verdu, E.F., Collins, S.M., The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141:2 (2011), 599–609 609 e591–593.
7. Berton, O., Nestler, E.J., New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7:2 (2006), 137–151.
8. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., Bienenstock, J., Cryan, J.F., Ingestion of lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U. S. A. 108:38 (2011), 16050–16055.
9. Bruce-Keller, A.J., Salbaum, J.M., Luo, M., Blanchard, E.t., Taylor, C.M., Welsh, D.A., Berthoud, H.R., Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biol. Psychiatry 77:7 (2015), 607–615.
10. Calfa, G., Kademian, S., Ceschin, D., Vega, G., Rabinovich, G.A., Volosin, M., Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment. Psychoneuroendocrinology 28:5 (2003), 687–701.
11. Clarke, G., Fitzgerald, P., Cryan, J.F., Cassidy, E.M., Quigley, E.M., Dinan, T.G., Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol., 9, 2009, 6.
12. Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R.D., Shanahan, F., Dinan, T.G., Cryan, J.F., The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 18:6 (2013), 666–673.
13. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13:10 (2012), 701–712.
14. Cryan, J.F., Dinan, T.G., Gut microbiota: microbiota and neuroimmune signalling-Metchnikoff to microglia. Nat. Rev. Gastroenterol. Hepatol. 12:9 (2015), 494–496.
15. De Filippis, F., Pellegrini, N., Vannini, L., Jeffery, I.B., La Storia, A., Laghi, L., Serrazanetti, D.I., Di Cagno, R., Ferrocino, I., Lazzi, C., Turroni, S., Cocolin, L., Brigidi, P., Neviani, E., Gobbetti, M., O'Toole, P.W., Ercolini, D., High-level adherence to a mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut, 2015.
16. De Palma, G., Blennerhassett, P., Lu, J., Deng, Y., Park, A.J., Green, W., Denou, E., Silva, M.A., Santacruz, A., Sanz, Y., Surette, M.G., Verdu, E.F., Collins, S.M., Bercik, P., Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat. Commun., 6, 2015, 7735.
17. Desbonnet, L., Clarke, G., Shanahan, F., Dinan, T.G., Cryan, J.F., Microbiota is essential for social development in the mouse. Mol. Psychiatry 19:2 (2014), 146–148.
18. Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J.F., Dinan, T.G., Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170:4 (2010), 1179–1188.
19. Dinan, T.G., Inflammatory markers in depression. Curr. Opin. Psychiatry 22:1 (2009), 32–36.
20. Dinan, T.G., Cryan, J.F., Melancholic microbes: a link between gut microbiota and depression?. Neurogastroenterol. Motil.: Off. J. Eur. Gastrointest. Motil. Soc. 25:9 (2013), 713–719.
21. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctot, K.L., A meta-analysis of cytokines in major depression. Biol. Psychiatry 67:5 (2010), 446–457.
22. Eaton, W.W., Shao, H., Nestadt, G., Lee, H.B., Bienvenu, O.J., Zandi, P., Population-based study of first onset and chronicity in major depressive disorder. Arch. General Psychiatry 65:5 (2008), 513–520.
23. El Aidy, S., Derrien, M., Aardema, R., Hooiveld, G., Richards, S.E., Dane, A., Dekker, J., Vreeken, R., Levenez, F., Dore, J., Zoetendal, E.G., van Baarlen, P., Kleerebezem, M., Transient inflammatory-like state and microbial dysbiosis are pivotal in establishment of mucosal homeostasis during colonisation of germ-free mice. Benef. Microbes 5:1 (2014), 67–77.
24. El Aidy, S., Kunze, W., Bienenstock, J., Kleerebezem, M., The microbiota and the gut-brain axis: insights from the temporal and spatial mucosal alterations during colonisation of the germfree mouse intestine. Benef. Microbes 3:4 (2012), 251–259.
25. Fava, M., Diagnosis and definition of treatment-resistant depression. Biol. Psychiatry 53:8 (2003), 649–659.
26. Frost, G., Sleeth, M.L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., Anastasovska, J., Ghourab, S., Hankir, M., Zhang, S., Carling, D., Swann, J.R., Gibson, G., Viardot, A., Morrison, D., Louise Thomas, E., Bell, J.D., The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun., 5, 2014, 3611.
27. Gorard, D.A., Gomborone, J.E., Libby, G.W., Farthing, M.J., Intestinal transit in anxiety and depression. Gut 39:4 (1996), 551–555.
28. Gustafsson, H., Nordstrom, A., Nordstrom, P., Depression and subsequent risk of Parkinson disease: a nationwide cohort study. Neurology 84:24 (2015), 2422–2429.
29. Haug, T.T., Mykletun, A., Dahl, A.A., Are anxiety and depression related to gastrointestinal symptoms in the general population?. Scand. J. Gastroenterology 37:3 (2002), 294–298.
30. Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., Codelli, J.A., Chow, J., Reisman, S.E., Petrosino, J.F., Patterson, P.H., Mazmanian, S.K., Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155:7 (2013), 1451–1463.
31. Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., Li, L., Ruan, B., Altered fecal microbiota composition in patients with major depressive disorder. Brain, Behav. Immun. 48 (2015), 186–194.
32. Jokela, M., Hamer, M., Singh-Manoux, A., Batty, G.D., Kivimaki, M., Association of metabolically healthy obesity with depressive symptoms: pooled analysis of eight studies. Mol. Psychiatry 19:8 (2014), 910–914.
33. Julio-Pieper, M., Bravo, J.A., Aliaga, E., Gotteland, M., Review article: intestinal barrier dysfunction and central nervous system disorders–a controversial association. Aliment. Pharmacol. Ther. 40:10 (2014), 1187–1201.
34. Kelly, J.R., Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Hyland, N.P., Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front. Cell. Neurosci., 9, 2015, 392.
35. Kelly, J.R., Clarke, G., Cryan, J.F., Dinan, T.G., Brain-gut-microbiota axis: challenges for translation in psychiatry. Ann. Epidemiol 26:5 (2016), 366–372.
36. Keri, S., Szabo, C., Kelemen, O., Expression of toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder. Brain, Behav. Immun. 40 (2014), 235–243.
37. Luczynski, P., McVey Neufeld, K.A., Oriach, C.S., Clarke, G., Dinan, T.G., Cryan, J.F., Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int. J. Neuropsychopharmacology/Official Sci. J. Coll. Int. Neuropsychopharmacol. (CINP), 2016.
38. Maes, M., Fisar, Z., Medina, M., Scapagnini, G., Nowak, G., Berk, M., New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates–Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 20:3 (2012), 127–150.
39. Maes, M., Kubera, M., Leunis, J.C., The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol. Lett. 29:1 (2008), 117–124.
40. Maes, M., Kubera, M., Leunis, J.C., Berk, M., Geffard, M., Bosmans, E., In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr. Scand. 127:5 (2013), 344–354.
41. Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.F., Rougeot, C., Pichelin, M., Cazaubiel, M., Cazaubiel, J.M., Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr. 105:5 (2011), 755–764.
42. Möhle, L., Mattei, D., Heimesaat, Markus M., Bereswill, S., Fischer, A., Alutis, M., French, T., Hambardzumyan, D., Matzinger, P., Dunay, Ildiko R., Wolf, Susanne A., Ly6Chi monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis. Cell Rep. 15:9 (2016), 1945–1956.
43. Naseribafrouei, A., Hestad, K., Avershina, E., Sekelja, M., Linlokken, A., Wilson, R., Rudi, K., Correlation between the human fecal microbiota and depression. Neurogastroenterology and motility. Official J. Eur. Gastrointest. Motil. Soc. 26:8 (2014), 1155–1162.
44. Nguyen, T.L.A., Vieira-Silva, S., Liston, A., Raes, J., How informative is the mouse for human gut microbiota research?. Dis. Models Mech. 8:1 (2015), 1–16.
45. O'Connor, J.C., Lawson, M.A., Andre, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K.W., Dantzer, R., Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 14:5 (2009), 511–522.
46. O'Mahony, S.M., Clarke, G., Borre, Y.E., Dinan, T.G., Cryan, J.F., Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Res. 277 (2015), 32–48.
47. O'Mahony, S.M., Marchesi, J.R., Scully, P., Codling, C., Ceolho, A.-M., Quigley, E.M.M., Cryan, J.F., Dinan, T.G., Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 65:18723164 (2009), 263–267.
48. Ogbonnaya, E.S., Clarke, G., Shanahan, F., Dinan, T.G., Cryan, J.F., O'Leary, O.F., Adult hippocampal neurogenesis is regulated by the microbiome. Biol. Psychiatry 78:4 (2015), e7–9.
49. Opie, R.S., Itsiopoulos, C., Parletta, N., Sanchez-Villegas, A., Akbaraly, T.N., Ruusunen, A., Jacka, F.N., Dietary recommendations for the prevention of depression. Nutr. Neurosci., 2015.
50. Pariante, C.M., Miller, A.H., Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 49:5 (2001), 391–404.
51. Park, A.J., Collins, J., Blennerhassett, P.A., Ghia, J.E., Verdu, E.F., Bercik, P., Collins, S.M., Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol. Motil. Official J. Eur. Gastrointest. Motil. Soc., 25(9), 2013 733–e575.
52. Savignac, H.M., Tramullas, M., Kiely, B., Dinan, T.G., Cryan, J.F., Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav. Brain Res. 287 (2015), 59–72.
53. Scheperjans, F., Aho, V., Pereira, P.A., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola-Rautio, J., Pohja, M., Kinnunen, E., Murros, K., Auvinen, P., Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. Official J. Mov. Disord. Soc. 30:3 (2015), 350–358.
54. Schmidt, K., Cowen, P.J., Harmer, C.J., Tzortzis, G., Errington, S., Burnet, P.W., Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology 232:10 (2015), 1793–1801.
55. Schroeder, F.A., Lin, C.L., Crusio, W.E., Akbarian, S., Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol. Psychiatry 62:1 (2007), 55–64.
56. Schwarcz, R., Bruno, J.P., Muchowski, P.J., Wu, H.Q., Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 13:7 (2012), 465–477.
57. Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J.A., Colzato, L.S., A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain, Behav. Immun. 48 (2015), 258–264.
58. Stetler, C., Miller, G.E., Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 73:2 (2011), 114–126.
59. Stilling, R.M., Ryan, F.J., Hoban, A.E., Shanahan, F., Clarke, G., Claesson, M.J., Dinan, T.G., Cryan, J.F., Microbes & neurodevelopment–Absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala. Brain, Behav. Immun. 50 (2015), 209–220.
60. Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., Kubo, C., Koga, Y., Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiology 558:Pt 1 (2004), 263–275.
61. Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain-Raspaud, S., Trotin, B., Naliboff, B., Mayer, E.A., Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144:7 (2013), 1394–1401 1401 e1391–1394.
62. Vijay, N., Morris, M.E., Role of monocarboxylate transporters in drug delivery to the brain. Curr. Pharm. Des. 20:10 (2014), 1487–1498.
63. Wei, Y., Melas, P.A., Wegener, G., Mathe, A.A., Lavebratt, C., Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. Int. J. Neuropsychopharmacology/Official Sci. J. Coll. Int. Neuropsychopharmacol. (CINP), 18(2), 2015.
64. WHO, The Global Burden of Disease 2004 Update. 2008.
65. Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., Nagler, C.R., Ismagilov, R.F., Mazmanian, S.K., Hsiao, E.Y., Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:2 (2015), 264–276.
66. Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., Zhang, X., Yang, D., Yang, Y., Meng, H., Li, W., Melgiri, N.D., Licinio, J., Wei, H., Xie, P., Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol. Psychiatry 21:6 (2016), 786–796.